Fractyl Health Inc (GUTS) stock shows 52-week fluctuation between $0.87 and $7.89

Fractyl Health Inc [GUTS] stock is trading at $2.12, up 25.44%. An important factor to consider is whether the stock is rising or falling in short-term value. The GUTS shares have gain 23.98% over the last week, with a monthly amount glided 73.77%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Previously, Morgan Stanley started tracking the stock with Overweight rating on February 27, 2024, and set its price target to $18. On February 27, 2024, BofA Securities initiated with a Buy rating and assigned a price target of $26 on the stock.

Fractyl Health Inc [GUTS] stock has fluctuated between $0.87 and $7.89 over the past year. Fractyl Health Inc [NASDAQ: GUTS] shares were valued at $2.12 at the most recent close of the market.

Analyzing the GUTS fundamentals

Fractyl Health Inc [NASDAQ:GUTS] reported sales of 0.06M for the trailing twelve months, which represents a drop of -100.00%. Gross Profit Margin for this corporation currently stands at -3.23% with Operating Profit Margin at -1612.47%, Pretax Profit Margin comes in at -1485.12%, and Net Profit Margin reading is -1485.12%. To continue investigating profitability, this company’s Return on Assets is posted at -1.07, Equity is -2.29 and Total Capital is -1.51. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of9.64.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.

Ratios To Look Out For

For context, Fractyl Health Inc’s Current Ratio is 2.50. On the other hand, the Quick Ratio is 2.50, and the Cash Ratio is 2.24. Considering the valuation of this stock, the price to sales ratio is 1730.50, the price to book ratio is 16.27.

Transactions by insiders

Recent insider trading involved Royan Ajay, Director, that happened on Mar 14 ’25 when 17901.0 shares were purchased. Director, Barnes Kelly Ann completed a deal on Mar 14 ’25 to buy 31000.0 shares. Meanwhile, Director SCHULMAN AMY W bought 8550.0 shares on Mar 13 ’25.

Related Posts

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.